Hematological malignancy

This page contains recent news articles, when available, and an overview of Hematological malignancy but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.

News: Hematological malignancy

Amgen Recognized for Best Pipeline and Best New Drug at Scrip Awards  -  23 Nov 2009
PR Newswire (press release)...of response to Nplate, and hematological malignancies and progression of malignancy in patients with a pre-existing hematological malignancy or MDS. ...

Berger to Speak at New York Academy of Sciences  -  ‎Oct 29, 2009‎
UK News..."Historically, this typically fatal viral disease of the brain had been largely seen as the consequence of underlying HIV/AIDS or hematological malignancy. ...

Innate Pharma initiates collaboration with Celgene to evaluate the clinical ...  -  ‎Nov 18, 2009‎
PipelineReview.com (press release)Multiple myeloma is the second most common hematological malignancy, with 40900 new cases diagnosed every year in the G7 countries. ...

New Report Just Published Pipeline Insight: Hematological ...  -  ‎Jul 19, 2009‎
Live-PR.com (Pressemitteilung)Smaller, niche indications are increasingly attracting R&D interest as a result of the high unmet needs that persist in a number of hematological malignancy

Geron Presents Interim Clinical Data on Its Telomerase Inhibitor ...  -  Dec 8, 2008
WELT ONLINE,Multiple myeloma is the second most common hematological malignancy of adults. The American Cancer Society has projected that 19900 new cases and 10790

Onconova Therapeutics Announces Publication of Positive Phase I ...  -  Oct 28, 2008
MarketWatchNa has shown broad-spectrum anti-tumor activity against both solid tumors and hematological malignancy and has demonstrated striking synergistic activity

Rituxan's status as market leader is unlikely to be challenged ...  -  Nov 9, 2008
Live-PR.com (Pressemitteilung),Non-Hodgkin's lymphoma (NHL) is the most common hematological malignancy and is comprised of around 30 different disease subtypes.

Cancer survivor rides again  -  Jul 2, 2008
Daily Nonpareil,...in a grassroots effort to raise money for hematological malignancy cancer and solid tumor cancer research at the University of Nebraska Medical Center.

FDA Approves VELCADE(R) (Bortezomib) for Injection for Patients ...  -  Jun 20, 2008
FOXBusinessMultiple myeloma is the second most common hematological malignancy. Between 2001 - 2005, the median age of diagnosis was 70 years.

Rituxan's status as market leader is unlikely to be challenged ...  -  Jun 18, 2008
PR-Inside.com (Pressemitteilung),Non-Hodgkin's lymphoma (NHL) is the most common hematological malignancy and is comprised of around 30 different disease subtypes.

Cytheris Announces New Phase I Study of Interleukin-7 As ...  -  Apr 23, 2008
Business Wire (press release),Patients admitted to the study must have histologically confirmed non-lymphoid hematological malignancy such as acute myeloid leukemia (AML),

A Rare Trifocal Presentation of Clostridium septicum Myonecrosis  -  Mar 10, 2008
Ortho SuperSite,11 Infection with C septicum may be associated with colorectal or hematological malignancy, diabetes mellitus, and drug-induced immunosuppression.

Millennium reports promising results for blood cancer drug  -  Mar 13, 2008
Boston Globe,Multiple myeloma is common hematological malignancy. In the United States, more than 55000 people, many of them elderly, have the disease, and about 20000

Publication of Clinical Results Underscores Velcade (Bortezomib ...  -  Mar 13, 2008
PharmaLive.com (press release),Multiple myeloma is the second most common hematological malignancy and although the disease is predominantly a cancer of the elderly (the median age of

Geron Initiates Clinical Trial of Telomerase Inhibitor Drug in ...  -  Nov 28, 2007
Business Wire (press release),Multiple myeloma is the second most common hematological malignancy of adults, accounting for 10% of the diagnoses of hematological malignancies in the

Get ready to take profits in biotech sector  -  Dec 15, 2007
Financial Post,The two most important conferences in the fourth quarter are the Hematological Malignancy conference in December and the JP Morgan health-care conference in



Background information on Hematological malignancy [When available]

Although hematological malignancies are a form of cancer, they are generally treated by specialists in hematology, although in many hospitals oncology specialists also manage these diseases. ("Hematology/Oncology" is a single subspecialty of Internal Medicine; there are also surgical and radiation oncologists.)

Hematological malignancies are the types of cancer that affect blood, bone marrow and lymph nodes. As the three are intimately connected through the immune system, a disease affecting one of the three will often affect the others as well: although lymphoma is technically a disease of the lymph nodes, it often spreads to the bone marrow, affecting the blood and occasionally producing a paraprotein.

Chromosomal translocations are a common cause of these diseases, while this is uncommon in solid tumors. This leads to a different approach in diagnosis and treatment of hematological malignancies.

Search the web for more resources on Hematological malignancy



Health Home | Conditions | Cancer | Medications | Surgery | Vaccines


The Cancer News Network


Disclaimer:

Contact a physician with regard to health concerns. Email requests for further health information will be discarded.

The materials contained on this Web site are for informational purposes only and do not constitute health or medical advice. Use of information on this site does not create or constitute any kind of agreement or contract between you and the owners or users of this site, the owners of the servers upon which it is housed, or anyone else who is in any way connected with this site.

Many links on cancernewsnetwork.org lead to other sites. cancernewsnetwork.org does not sponsor, endorse or otherwise approve of the materials appearing in such sites. Nor is CancerNewsNetwork.org responsible for dead or misdirected links.

IF YOU NEED A LINK OR TEXT REMOVED FROM THIS PAGE PLEASE CONTACT cancernewsnetwork (at) live.com.
We will do our best to accommodate your request.



COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy